Clear Street’s Drugs Made In America Acquisition II Corp Unit DMIIU Stock Holding History

Clear Street’s Portfolio DMIIU Stock Details DMIIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.1K	Sell	8,084 -158,558	-95%	-$1.6M	﹤0.01%	867
2026 Q1	$1.67M	Sell	166,642 -69,790	-30%	-$702K	0.01%	259
2025 Q4	$2.37M	Sell	236,432 -120,670	-34%	-$1.21M	0.01%	183
2025 Q3	$3.55M	Buy	+357,102	New	+$3.56M	0.01%	126

Other funds holding DMIIU

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Clear Street's DMIIU Position: Q2 2026 in Review

Clear Street reduced its Drugs Made In America Acquisition II Corp Unit (DMIIU) stake by 95% in Q2 2026, selling an estimated $1.6M and leaving 8,084 shares worth $82.1K. The position accounts for ﹤0.01% of the portfolio, ranked #867.

Clear Street first reported a position in DMIIU in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.55M in Q3 2025. 11 funds tracked by Wall St. Rank hold DMIIU as of Q2 2026.

Clear Street held 8,084 shares of Drugs Made In America Acquisition II Corp Unit worth $82.1K as of Q2 2026.
Clear Street sold 158,558 Drugs Made In America Acquisition II Corp Unit shares in Q2 2026, an estimated $1.6M.
Drugs Made In America Acquisition II Corp Unit made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #867 holding.
Clear Street first reported a position in Drugs Made In America Acquisition II Corp Unit in Q3 2025 and has held it in 4 quarters since.
Clear Street's Drugs Made In America Acquisition II Corp Unit position peaked at $3.55M in Q3 2025.
11 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Unit as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.